Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.
AffiliationCRUK-EPSRC Cancer Imaging Centre in Cambridge and Manchester, University of Manchester, Manchester, United Kingdom
MetadataShow full item record
AbstractTumors exhibit genomic and phenotypic heterogeneity, which has prognostic significance and may influence response to therapy. Imaging can quantify the spatial variation in architecture and function of individual tumors through quantifying basic biophysical parameters such as CT density or MRI signal relaxation rate; through measurements of blood flow, hypoxia, metabolism, cell death, and other phenotypic features; and through mapping the spatial distribution of biochemical pathways and cell signaling networks using PET, MRI, and other emerging molecular imaging techniques. These methods can establish whether one tumor is more or less heterogeneous than another and can identify subregions with differing biology. In this article, we review the image analysis methods currently used to quantify spatial heterogeneity within tumors. We discuss how analysis of intratumor heterogeneity can provide benefit over more simple biomarkers such as tumor size and average function. We consider how imaging methods can be integrated with genomic and pathology data, instead of being developed in isolation. Finally, we identify the challenges that must be overcome before measurements of intratumoral heterogeneity can be used routinely to guide patient care.
CitationImaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. 2015, 21 (2):249-57 Clin Cancer Res
JournalClinical Cancer Research
- Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
- Authors: Kim JY, Gatenby RA
- Issue date: 2017
- Cancer heterogeneity and imaging.
- Authors: O'Connor JPB
- Issue date: 2017 Apr
- Quantifying heterogeneity in human tumours using MRI and PET.
- Authors: Asselin MC, O'Connor JP, Boellaard R, Thacker NA, Jackson A
- Issue date: 2012 Mar
- Investigation of realistic PET simulations incorporating tumor patient's specificity using anthropomorphic models: creation of an oncology database.
- Authors: Papadimitroulas P, Loudos G, Le Maitre A, Hatt M, Tixier F, Efthimiou N, Nikiforidis GC, Visvikis D, Kagadis GC
- Issue date: 2013 Nov
- Intratumor heterogeneity: nature and biological significance.
- Authors: Gerashchenko TS, Denisov EV, Litviakov NV, Zavyalova MV, Vtorushin SV, Tsyganov MM, Perelmuter VM, Cherdyntseva NV
- Issue date: 2013 Nov